Poirot M, Chailleux C, Fargin A, Bayard F, Faye J C
Laboratoire d'Endocrinologie Expérimentale, CHU Rangueil, Toulouse, France.
J Biol Chem. 1990 Oct 5;265(28):17039-43.
The anti-estrogen binding site (ABS) is an apparently ubiquitous component of cells that has been shown to be intimately linked with the antiproliferative effects of certain antiestrogenic compounds, like tamoxifen, which is currently used for the treatment of breast cancer. However, the identification and in vitro study of this novel protein has been hampered to date by a lack of convenient probes that will efficiently label the molecule in nonpurified preparations. Thus, using a selective ABS ligand (4-benzylphenoxy-N-ethylmorpholine, MBPE) as starting material, we synthesized a photosensitive azido derivative, [(2-azido-4-benzyl)phenoxy]N-ethylmorpholine (azido-MBPE) that can be prepared in a tritiated form. Azido-MBPE has a high affinity for ABS (Kd = 3 nM), identical to that of tamoxifen, and covalently labels 5 and 12% of membrane-bound and detergent-solubilized ABS, respectively. Its incorporation is selectively and competitively inhibited by other ABS ligands (tamoxifen greater than nitromifen greater than hydroxytamoxifen). [3H]Azido-MBPE potently photolabels either membrane-bound or detergent-solubilized ABS as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under denaturing conditions revealing specific photoincorporation in a protein band of Mr = 40,000. This molecular weight is approximately two times lower than what we observed previously for ABS preparations studied under nondenaturing conditions and postlabeled with [3H]tamoxifen (Mr = 80,000-110,000). In chromatofocusing experiments with photolabeled ABS, a single specifically labeled protein fraction migrating with a pI of 6.4 was found to exhibit a Mr of 40,000 when subsequently electrophoresed on sodium dodecyl sulfate-polyacrylamide gels. These results indicate that [3H]azido-MBPE is a specific high affinity probe of ABS that will prove useful in the ultimate identification of this protein.
抗雌激素结合位点(ABS)显然是细胞中普遍存在的一种成分,已被证明与某些抗雌激素化合物(如目前用于治疗乳腺癌的他莫昔芬)的抗增殖作用密切相关。然而,由于缺乏能在非纯化制剂中有效标记该分子的便捷探针,迄今为止,这种新型蛋白质的鉴定和体外研究受到了阻碍。因此,我们以一种选择性ABS配体(4-苄基苯氧基-N-乙基吗啉,MBPE)为起始原料,合成了一种可制成氚化形式的光敏叠氮衍生物,即[(2-叠氮基-4-苄基)苯氧基]N-乙基吗啉(叠氮基-MBPE)。叠氮基-MBPE对ABS具有高亲和力(解离常数Kd = 3 nM),与他莫昔芬相同,并且分别共价标记5%和12%的膜结合型和去污剂增溶型ABS。其掺入受到其他ABS配体(他莫昔芬>硝米芬>羟基他莫昔芬)的选择性和竞争性抑制。在变性条件下通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定,[3H]叠氮基-MBPE能有效地光标记膜结合型或去污剂增溶型ABS,在Mr = 40,000的蛋白条带中显示出特异性光掺入。该分子量比我们之前在非变性条件下研究并用[3H]他莫昔芬进行后标记的ABS制剂(Mr = 80,000 - 110,000)低约两倍。在对光标记的ABS进行色谱聚焦实验时,发现一个单一的特异性标记蛋白组分,其等电点为6.4,当随后在十二烷基硫酸钠-聚丙烯酰胺凝胶上进行电泳时,其Mr为40,000。这些结果表明,[3H]叠氮基-MBPE是一种特异性高亲和力的ABS探针,将被证明对最终鉴定该蛋白有用。